AN4005

· Adlai Nortye Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AN4005, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: First in Human, Dose Escalation Study of AN4005 [Phase 1]